1. Home
  2. EPR vs BLTE Comparison

EPR vs BLTE Comparison

Compare EPR & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EPR Properties

EPR

EPR Properties

HOLD

Current Price

$50.15

Market Cap

4.4B

Sector

Real Estate

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$141.34

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EPR
BLTE
Founded
1997
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.1B
IPO Year
1997
2022

Fundamental Metrics

Financial Performance
Metric
EPR
BLTE
Price
$50.15
$141.34
Analyst Decision
Buy
Strong Buy
Analyst Count
11
6
Target Price
$57.06
$149.00
AVG Volume (30 Days)
609.7K
289.5K
Earning Date
10-29-2025
11-10-2025
Dividend Yield
7.07%
N/A
EPS Growth
N/A
N/A
EPS
2.29
N/A
Revenue
$707,150,000.00
N/A
Revenue This Year
$5.11
N/A
Revenue Next Year
$2.70
N/A
P/E Ratio
$21.91
N/A
Revenue Growth
3.73
N/A
52 Week Low
$41.75
$49.00
52 Week High
$61.24
$161.32

Technical Indicators

Market Signals
Indicator
EPR
BLTE
Relative Strength Index (RSI) 38.11 58.44
Support Level $49.41 $140.07
Resistance Level $51.80 $161.32
Average True Range (ATR) 0.94 12.21
MACD -0.15 -1.03
Stochastic Oscillator 20.14 56.47

Price Performance

Historical Comparison
EPR
BLTE

About EPR EPR Properties

EPR Properties is a real estate investment trust that focuses on underwriting experiential property investments on key industry and property cash flow criteria, and the credit metrics of tenants and customers. The company invests in two property segments: Experiential, including theaters, family entertainment centers, ski resorts, and other attractions; and Education, including early childhood education centers and private school properties. The Company's business is focused on Experiential real estate. The majority of revenue comes from the Experiential sector.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: